83 FR 18627 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 83, Issue 82 (April 27, 2018)
Federal Motor Carrier Safety Administration
Federal Register Volume 83, Issue 82 (April 27, 2018)
| Page Range | 18627-18633 | |
| FR Document | 2018-08909 |
[Federal Register Volume 83, Number 82 (Friday, April 27, 2018)] [Notices] [Pages 18627-18633] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-08909] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2018-0025] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of applications for exemption; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 40 individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with insulin-treated diabetes mellitus (ITDM) operating a commercial motor vehicle (CMV) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before May 29, 2018. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2018-0025 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket number(s) for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The FDMS is available 24 hours each day e.t., 365 days each year. If you want acknowledgment that we received your comments, please include a self-addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments online. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to http://www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at http://www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, [[Page 18628]] Department of Transportation, 1200 New Jersey Avenue, SE, Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the FMCSRs for a five-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the five-year period. FMCSA grants exemptions from the FMCSRs for a two- year period to align with the maximum duration of a driver's medical certification. The 40 individuals listed in this notice have requested an exemption from the diabetes prohibition in 49 CFR 391.41(b)(3). Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. The physical qualification standard for drivers regarding diabetes found in 49 CFR 391.41(b)(3) states that a person is physically qualified to drive a CMV if that person has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control. The Agency established the current requirement for diabetes in 1970 because several risk studies indicated that drivers with diabetes had a higher rate of crash involvement than the general population. FMCSA established its diabetes exemption program, based on the Agency's July 2000 study entitled ``A Report to Congress on the Feasibility of a Program to Qualify Individuals with Insulin-Treated Diabetes Mellitus to Operate in Interstate Commerce as Directed by the Transportation Act for the 21st Century.'' The report concluded that a safe and practicable protocol to allow some drivers with ITDM to operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal Register notice in conjunction with the November 8, 2005 (70 FR 67777), Federal Register notice provides the current protocol for allowing such drivers to operate CMVs in interstate commerce. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441). The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). Section 4129 requires: (1) Elimination of the requirement for three years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the three-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C. 31136(e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003, notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003, notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. II. Qualifications of Applicants Waael Abuhijab Mr. Abuhijab, 34, has had ITDM since 2008. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Abuhijab understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Abuhijab meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from California. Patrick S. Baker Mr. Baker, 40, has had ITDM since 2015. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Baker understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Baker meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Virginia. Thomas E. Bandy Mr. Bandy, 40, has had ITDM since 2006. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Bandy understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bandy meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Nebraska. Douglas E. Barron Mr. Barron, 50, has had ITDM since 1981. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Barron understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV [[Page 18629]] safely. Mr. Barron meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from South Carolina. Michael R. Batey Mr. Batey, 53, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Batey understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Batey meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Wayne A. Buechler Mr. Beuchler, 57, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Beuchler understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Beuchler meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Dakota. Alexander R. Castell Mr. Castell, 23, has had ITDM since 2011. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Castell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Castell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Iowa. Jeffrey S. Chandler Mr. Chandler, 51, has had ITDM since 1982. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Chandler understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Chandler meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Robert D. Clark, Jr. Mr. Clark, 64, has had ITDM since 2007. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Clark understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Clark meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New York. Jimmy D. Coffman Mr. Coffman, 57, has had ITDM since 1983. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Coffman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Coffman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Texas. Dale L. Collin Mr. Collin, 52, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Collin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Collin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. Wilfredo Costa Mr. Costa, 62, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Costa understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Costa meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from New York. Jeffrey L. Covert Mr. Covert, 48, has had ITDM since 2008. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist [[Page 18630]] certifies that Mr. Covert understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Covert meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Arkansas. Terry L. Emenheiser Mr. Emenheiser, 52, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Emenheiser understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Emenheiser meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Brendan T. Farnam Mr. Farnam, 24, has had ITDM since 1997. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Farnam understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Farnam meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Massachusetts. Gerard R. Galipeau, Jr. Mr. Galipeau, 49, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Galipeau understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Galipeau meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Maine. Steve A. Holifield Mr. Holifield, 62, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Holifield understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Holifield meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Mississippi. Jerry W. Howell Mr. Howell, 72, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Howell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Howell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Arkansas. Stephen M. Huckleby Mr. Huckleby, 30, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Huckleby understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Huckleby meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Kentucky. David L. Isreal Mr. Isreal, 46, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Isreal understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Isreal meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Missouri. Eric D. Kennedy Mr. Kennedy, 42, has had ITDM since 1990. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Kennedy understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kennedy meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Connecticut. Jeff F. Kress Mr. Kress, 63, has had ITDM since 2015. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting [[Page 18631]] in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Kress understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kress meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Minnesota. John K. Laughlin Mr. Laughlin, 32, has had ITDM since 2005. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Laughlin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Laughlin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Louisiana. Alfred G. Love, 3rd Mr. Love, 63, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Love understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Love meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Delaware. Gerald P. Malone Mr. Malone, 56, has had ITDM since 2002. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Malone understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Malone meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Volodymyr Marchenko Mr. Marchenko, 28, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Marchenko understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Marchenko meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from California. Wayne R. Miller Mr. Miller, 62, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Miller understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Miller meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Virginia. Kennedy T. Moore Mr. Moore, 47, has had ITDM since 2011. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Moore understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Moore meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Florida. John A. Morth Mr. Morth, 36, has had ITDM since 2010. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Morth understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Morth meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Ohio. Keith E. Nichols Mr. Nichols, 60, has had ITDM since 2012. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Nichols understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Nichols meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that [[Page 18632]] he does not have diabetic retinopathy. He holds an operator's license from Iowa. Craig E. Paczkowski Mr. Paczkowski, 53, has had ITDM since 2004. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Paczkowski understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Paczkowski meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Florida. Michael J. Pollart Mr. Pollart, 27, has had ITDM since 2006. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Pollart understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Pollart meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Rhode Island. James D. Reynolds Mr. Reynolds, 64, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Reynolds understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Reynolds meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Jordin R. Rhone Mr. Rhone, 25, has had ITDM since 2001. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Rhone understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Rhone meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New York. Nathaniel B. Shaw Mr. Shaw, 32, has had ITDM since 2003. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Shaw understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Shaw meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Timothy H. Solomon Mr. Solomon, 55, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Solomon understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Solomon meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Minnesota. Mark A. Tevis Mr. Tevis, 58, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Tevis understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tevis meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Indiana. Richard D. Tripp Mr. Tripp, 64, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Tripp understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tripp meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from South Dakota. Ismael Vasquez Mr. Vasquez, 56, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in [[Page 18633]] the last five years. His endocrinologist certifies that Mr. Vasquez understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Vasquez meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from California. Travis J. Womack Mr. Womack, 33, has had ITDM since 1993. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Womack understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Womack meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from North Carolina. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the dates section of the notice. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2018-0025 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and materials received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2018-0025 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: April 18, 2018. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2018-08909 Filed 4-26-18; 8:45 am] BILLING CODE 4910-EX-P
![Federal Register / Vol. 83, No. 82 / Friday, April 27, 2018 / Notices 18627
and includes the following: (1) Each Deavan T. Jones (MN) vehicle (CMV) in interstate commerce. If
driver must submit a quarterly Bryant C. Kongsted (MD) granted, the exemptions would enable
monitoring checklist completed by the Sandra K. Kostka (MN) these individuals with ITDM to operate
treating endocrinologist as well as an Geoffrey A. Kusman (IL) CMVs in interstate commerce.
annual checklist with a comprehensive Chadwick L. Lekwa (IA) DATES: Comments must be received on
medical evaluation; (2) each driver must Craig W. Lockwood (WI) or before May 29, 2018.
report within two business days of Joseph A. Malone (CA) ADDRESSES: You may submit comments
occurrence, all episodes of severe Chance P. Masterson (OR) bearing the Federal Docket Management
hypoglycemia, significant Harold W. Meade (VA) System (FDMS) Docket No. FMCSA–
complications, or inability to manage Korey E. Molina (VA) 2018–0025 using any of the following
diabetes; also, any involvement in an Steven G. Ojala (WA) methods:
accident or any other adverse event in Kathy L. Pospichal (WI) • Federal eRulemaking Portal: Go to
a CMV or personal vehicle, whether or Robert S. Reyes (CA) http://www.regulations.gov. Follow the
not it is related to an episode of Robert D. Risk (IN) online instructions for submitting
hypoglycemia; (3) each driver must David L. Robson (IA) comments.
provide a copy of the ophthalmologist’s Todd D. Rue (MN) • Mail: Docket Management Facility;
or optometrist’s report to the Medical Luis A. Saavedra (TX) U.S. Department of Transportation, 1200
Examiner at the time of the annual Timothy S. Smith (NC) New Jersey Avenue SE, West Building
medical examination; and (4) each Michael E. Smyth (ID) Ground Floor, Room W12–140,
driver must provide a copy of the Dennis N. Spake (VA) Washington, DC 20590–0001.
annual medical certification to the Vincent F. Strafford (NC) • Hand Delivery: West Building
employer for retention in the driver’s Frederick W. Stevens (OH) Ground Floor, Room W12–140, 1200
qualification file, or keeping a copy in Jason E. Stocker (VT) New Jersey Avenue SE, Washington,
his/her driver’s qualification file if he/ Thomas L. Tallon (WA) DC, between 9 a.m. and 5 p.m., e.t.,
she is self-employed. The driver must Michael L. Vanalstine (OH) Monday through Friday, except Federal
also have a copy of the exemption when Ralph O. Weathers (IN) Holidays.
driving, for presentation to a duly In accordance with 49 U.S.C. 31136(e) • Fax: 1–202–493–2251.
authorized Federal, State, or local and 31315, each exemption will be valid Instructions: Each submission must
enforcement official. for two years from the effective date include the Agency name and the
unless revoked earlier by FMCSA. The docket number(s) for this notice. Note
VI. Preemption
exemption will be revoked if the that all comments received will be
During the period the exemption is in following occurs: (1) The person fails to posted without change to http://
effect, no State shall enforce any law or comply with the terms and conditions www.regulations.gov, including any
regulation that conflicts with this of the exemption; (2) the exemption has personal information provided. Please
exemption with respect to a person resulted in a lower level of safety than see the Privacy Act heading below for
operating under the exemption. was maintained prior to being granted; further information.
or (3) continuation of the exemption Docket: For access to the docket to
VII. Conclusion
would not be consistent with the goals read background documents or
Based upon its evaluation of the 51 and objectives of 49 U.S.C. 31136(e) and comments, go to http://
exemption applications, FMCSA 31315. www.regulations.gov at any time or
exempts the following drivers from the Room W12–140 on the ground level of
diabetes requirement in 49 CFR Issued on: April 18, 2018.
the West Building, 1200 New Jersey
391.41(b)(10), subject to the Larry W. Minor,
Avenue SE, Washington, DC, between 9
requirements cited above: Associate Administrator for Policy. a.m. and 5 p.m., e.t., Monday through
Carl W. Anderson (PA) [FR Doc. 2018–08923 Filed 4–26–18; 8:45 am] Friday, except Federal holidays. The
Thomas J. Anderson (CA) BILLING CODE 4910–EX–P FDMS is available 24 hours each day
Jorge A. Barra-Del Valle (UT) e.t., 365 days each year. If you want
Jeffery L. Bennett (IL) acknowledgment that we received your
William T. Bookamer, Jr. (TN) DEPARTMENT OF TRANSPORTATION comments, please include a self-
Ronnie J. Boyd (TN) addressed, stamped envelope or
Travis R. Breakiron (PA) Federal Motor Carrier Safety
postcard or print the acknowledgement
Corey D. Calvert (WI) Administration
page that appears after submitting
Jon Conley (OH) [Docket No. FMCSA–2018–0025] comments online.
Kiva J. Coppage (MO) Privacy Act: In accordance with 5
Peter F. Cox (MA) Qualification of Drivers; Exemption U.S.C. 553(c), DOT solicits comments
Kerry P. Daniels (WA) Applications; Diabetes Mellitus from the public to better inform its
Joshua M. Dekker (MI) rulemaking process. DOT posts these
Miguel A. Disla (VA) AGENCY: Federal Motor Carrier Safety
Administration (FMCSA), DOT. comments, without edit, including any
Jon R. Easterla (IL) personal information the commenter
Andrew W. Erickson (WY) ACTION: Notice of applications for
provides, to http://www.regulations.gov,
Martie L. Eubanks (MO) exemption; request for comments. as described in the system of records
Dwight G. Farnworth (ID)
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY: FMCSA announces receipt of notice (DOT/ALL–14 FDMS), which can
John A. Gott (MD)
applications from 40 individuals for an be reviewed at http://www.dot.gov/
Ian C. Hall (MI)
exemption from the prohibition in the privacy.
Carl L. Harville, Jr. (VA)
Terry L. Helderman (IL) Federal Motor Carrier Safety FOR FURTHER INFORMATION CONTACT: Ms.
James M. Hershey (WA) Regulations (FMCSRs) against persons Christine A. Hydock, Chief, Medical
Glee D. Jacobs (KS) with insulin-treated diabetes mellitus Programs Division, (202) 366–4001,
Thomas V. Johnson (IN) (ITDM) operating a commercial motor fmcsamedical@dot.gov, FMCSA,
VerDate Sep<11>2014 18:18 Apr 26, 2018 Jkt 244001 PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 E:\FR\FM\27APN1.SGM 27APN1](https://thefederalregister.org/doc/83_FR_18709/page/1.svg)
![Federal Register / Vol. 83, No. 82 / Friday, April 27, 2018 / Notices 18633
the last five years. His endocrinologist provide a reason for each suggestion or regarding viewing or submitting
certifies that Mr. Vasquez understands recommendation. If you submit your material to the docket, contact Docket
diabetes management and monitoring, comments by mail or hand delivery, Services, telephone (202) 366–9826.
has stable control of his diabetes using submit them in an unbound format, no
SUPPLEMENTARY INFORMATION:
insulin, and is able to drive a CMV larger than 81⁄2 by 11 inches, suitable for
safely. Mr. Vasquez meets the copying and electronic filing. If you I. Electronic Access
requirements of the vision standard at submit comments by mail and would
49 CFR 391.41(b)(10). His optometrist like to know that they reached the You may see all the comments online
examined him in 2017 and certified that facility, please enclose a stamped, self- through the Federal Document
he does not have diabetic retinopathy. addressed postcard or envelope. Management System (FDMS) at: http://
He holds a Class A CDL from California. We will consider all comments and www.regulations.gov.
Travis J. Womack materials received during the comment Docket: For access to the docket to
period. FMCSA may issue a final read background documents or
Mr. Womack, 33, has had ITDM since determination at any time after the close comments, go to http://
1993. His endocrinologist examined him of the comment period. www.regulations.gov and/or Room
in 2017 and certified that he has had no W12–140 on the ground level of the
severe hypoglycemic reactions resulting V. Viewing Comments and Documents
West Building, 1200 New Jersey Avenue
in loss of consciousness, requiring the To view comments, as well as any SE, Washington, DC, between 9 a.m. and
assistance of another person, or documents mentioned in this preamble, 5 p.m., e.t., Monday through Friday,
resulting in impaired cognitive function go to http://www.regulations.gov and in except Federal holidays.
that occurred without warning in the the search box insert the docket number
past 12 months and no recurrent (two or Privacy Act: In accordance with 5
FMCSA–2018–0025 and click ‘‘Search.’’ U.S.C. 553(c), DOT solicits comments
more) severe hypoglycemic episodes in Next, click ‘‘Open Docket Folder’’ and
the last five years. His endocrinologist from the public to better inform its
you will find all documents and rulemaking process. DOT posts these
certifies that Mr. Womack understands comments related to this notice.
diabetes management and monitoring, comments, without edit, including any
Issued on: April 18, 2018. personal information the commenter
has stable control of his diabetes using
insulin, and is able to drive a CMV Larry W. Minor, provides, to http://www.regulations.gov,
safely. Mr. Womack meets the Associate Administrator for Policy. as described in the system of records
requirements of the vision standard at [FR Doc. 2018–08909 Filed 4–26–18; 8:45 am] notice (DOT/ALL–14 FDMS), which can
49 CFR 391.41(b)(10). His BILLING CODE 4910–EX–P be reviewed at http://www.dot.gov/
ophthalmologist examined him in 2017 privacy.
and certified that he has stable II. Background
nonproliferative diabetic retinopathy. DEPARTMENT OF TRANSPORTATION
He holds an operator’s license from On February 14, 2018, FMCSA
Federal Motor Carrier Safety published a notice announcing receipt
North Carolina.
Administration of applications from 26 individuals
III. Request for Comments requesting an exemption from diabetes
[FMCSA Docket No. FMCSA–2017–0289]
In accordance with 49 U.S.C. 31136(e) requirement in 49 CFR 391.41(b)(3) and
and 31315, FMCSA requests public Qualification of Drivers; Exemption requested comments from the public (83
comment from all interested persons on Applications; Diabetes Mellitus FR 6725). The public comment period
the exemption petitions described in ended on March 16, 2017, and one
AGENCY: Federal Motor Carrier Safety
this notice. We will consider all comment was received.
Administration (FMCSA), DOT.
comments received before the close of FMCSA has evaluated the eligibility
business on the closing date indicated ACTION: Notice of final disposition.
of these applicants and determined that
in the dates section of the notice. SUMMARY: FMCSA announces its granting the exemptions to these
IV. Submitting Comments decision to exempt 26 individuals from individuals would achieve a level of
the prohibition in the Federal Motor safety equivalent to or greater than the
You may submit your comments and
Carrier Safety Regulations (FMCSRs) level that would be achieved by
material online or by fax, mail, or hand
against persons with insulin-treated complying with the current regulation
delivery, but please use only one of
diabetes mellitus (ITDM) from operating 49 CFR 391.41(b)(3).
these means. FMCSA recommends that
you include your name and a mailing a commercial motor vehicle (CMV) in The physical qualification standard
address, an email address, or a phone interstate commerce. The exemptions for drivers regarding diabetes found in
number in the body of your document enable these individuals with ITDM to 49 CFR 391.41(b)(3) states that a person
so that FMCSA can contact you if there operate CMVs in interstate commerce. is physically qualified to drive a CMV
are questions regarding your DATES: The exemptions were applicable if that person has no established
submission. on March 17, 2018. The exemptions medical history or clinical diagnosis of
To submit your comment online, go to expire on March 17, 2020. diabetes mellitus currently requiring
http://www.regulations.gov and in the FOR FURTHER INFORMATION CONTACT: Ms. insulin for control.
search box insert the docket number Christine A. Hydock, Chief, Medical III. Discussion of Comments
FMCSA–2018–0025 and click the search Programs Division, (202) 366–4001,
daltland on DSKBBV9HB2PROD with NOTICES
button. When the new screen appears, fmcsamedical@dot.gov, FMCSA, FMCSA received one comment in this
click on the blue ‘‘Comment Now!’’ Department of Transportation, 1200 proceeding. Vicky Johnson stated that
button on the right hand side of the New Jersey Avenue SE, Room W64–224, Minnesota Driver and Vehicle Services
page. On the new page, enter Washington, DC 20590–0001. Office (DVS) has no objections in granting
information required including the hours are from 8:30 a.m. to 5 p.m., e.t., exemptions to the following Minnesota
specific section of this document to Monday through Friday, except Federal drivers: Wade A. Demarais and David V.
which each comment applies, and holidays. If you have questions Bartel.
VerDate Sep<11>2014 18:18 Apr 26, 2018 Jkt 244001 PO 00000 Frm 00133 Fmt 4703 Sfmt 4703 E:\FR\FM\27APN1.SGM 27APN1](https://thefederalregister.org/doc/83_FR_18709/page/7.svg)
Document Created: 2018-04-27 01:44:37
Document Modified: 2018-04-27 01:44:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemption; request for comments. | |
| Dates | Comments must be received on or before May 29, 2018. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue, SE, Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826. | |
| FR Citation | 83 FR 18627 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR